VOYA Investment Management’s CytomX Therapeutics CTMX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-25,786
| Closed | -$69K | – | 2797 |
|
2022
Q1 | $69K | Sell |
25,786
-545
| -2% | -$1.46K | ﹤0.01% | 2560 |
|
2021
Q4 | $114K | Sell |
26,331
-158
| -0.6% | -$684 | ﹤0.01% | 2650 |
|
2021
Q3 | $134K | Buy |
26,489
+188
| +0.7% | +$951 | ﹤0.01% | 2676 |
|
2021
Q2 | $166K | Buy |
26,301
+2,579
| +11% | +$16.3K | ﹤0.01% | 2657 |
|
2021
Q1 | $183K | Buy |
23,722
+4,118
| +21% | +$31.8K | ﹤0.01% | 2566 |
|
2020
Q4 | $128K | Buy |
19,604
+4,007
| +26% | +$26.2K | ﹤0.01% | 2515 |
|
2020
Q3 | $104K | Hold |
15,597
| – | – | ﹤0.01% | 2333 |
|
2020
Q2 | $130K | Sell |
15,597
-7,602
| -33% | -$63.4K | ﹤0.01% | 2286 |
|
2020
Q1 | $178K | Hold |
23,199
| – | – | ﹤0.01% | 2168 |
|
2019
Q4 | $193K | Buy |
23,199
+3,852
| +20% | +$32K | ﹤0.01% | 2384 |
|
2019
Q3 | $143K | Hold |
19,347
| – | – | ﹤0.01% | 2320 |
|
2019
Q2 | $217K | Buy |
19,347
+1,306
| +7% | +$14.6K | ﹤0.01% | 2258 |
|
2019
Q1 | $194K | Hold |
18,041
| – | – | ﹤0.01% | 2278 |
|
2018
Q4 | $272K | Buy |
18,041
+1,862
| +12% | +$28.1K | ﹤0.01% | 2084 |
|
2018
Q3 | $299K | Buy |
16,179
+1,223
| +8% | +$22.6K | ﹤0.01% | 2149 |
|
2018
Q2 | $342K | Buy |
14,956
+1,868
| +14% | +$42.7K | ﹤0.01% | 2069 |
|
2018
Q1 | $372K | Hold |
13,088
| – | – | ﹤0.01% | 1982 |
|
2017
Q4 | $276K | Hold |
13,088
| – | – | ﹤0.01% | 2183 |
|
2017
Q3 | $238K | Hold |
13,088
| – | – | ﹤0.01% | 2299 |
|
2017
Q2 | $203K | Buy |
+13,088
| New | +$203K | ﹤0.01% | 2403 |
|